Champions Oncology Inc

CSBR03 Dec 2024
Healthcare
$4.56
-0.02 (-1.95%)
Lowest Today
$4.33
Highest Today
$4.56
Today’s Open
$4.56
Prev. Close
$4.52
52 Week High
$7.13
52 Week Low
$3.6
To Invest in Champions Oncology Inc

Champions Oncology Inc

Healthcare
CSBR03 Dec 2024
-0.02 (-1.95%)
1M
3M
6M
1Y
5Y
Low
$4.33
Day’s Range
High
$4.56
4.33
52 Week Low
$3.6
52-Week Range
52 Week High
$7.13
3.6
1 Day
-
1 Week
-
1 month return
+5.53%
3 month return
+4.06%
6 month return
-19.92%
1 Year return
-22.64%
3 Years return
-49.5%
5 Years return
-32.11%
10 Years return
-
Institutional Holdings
Battery Management Corp
17.81
NEA Management Company, LLC
12.61
Tocqueville Asset Management L.P.
5.19
Vanguard Group Inc
2.26
Vanguard Total Stock Mkt Idx Inv
1.73
Renaissance Technologies Corp
0.88
BlackRock Inc
0.85

Market Status

Fundamentals
Market Cap
58.59 mln
PB Ratio
6.77
PE Ratio
0
Enterprise Value
62.8 mln
Total Assets
26.13 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Organisation
Champions Oncology Inc
Employees
210
Industry
Biotechnology
CEO
Dr. Ronnie  Morris M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step